L3VLUP

TERN in the 13F filings

Terns Pharmaceuticals Inc · CUSIP 880881107

Quarter end
30 Jun 2024
the date the book describes
Filed
16 Sep 2024
latest of these filings; the earliest 14 Aug 2024
Managers listing it
4
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 1 listed it in both
Shares listed
5,784,218
combined, among listed positions
Reported value
$39m
combined, at the quarter end

Among the 94 comparable managers: 4 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing TERN in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

4 of 4 holders

ActionFiling
Point72 Asset Management LP2,690,376$18munder 0.1%Addedn.a.16 Sep 2024 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC2,268,428$15m0.10%Added+1,072,63414 Aug 2024 (the filing on sec.gov)
Woodline Partners LP745,044$5.1munder 0.1%Newnew14 Aug 2024 (the filing on sec.gov)
PDT Partners LLC80,370$547k0.05%Newnew15 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q2 2024 to 15 in Q1 2026

Tracked managers listing it, at least.

051015Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
TERN by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20241$7.8m10
Q2 20244$39m40
Q3 20244$66m31
Q4 20241$26m10
Q1 20251$11m01
Q2 20251$11m01
Q3 20251$14m01
Q4 20259$450m274
Q1 202615$769m2017

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

Choose a stock to compare with TERN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own TERN, latest filings →Back to the 13F Explorer →